🚨 I've spent weeks inside the Epstein files — not looking for names, but for infrastructure. What I found: Jeffrey Epstein wasn't just a sex trafficker. He was a switchboard — routing government secrets, Wall Street intelligence, and political power through one network. The same network that built the censorship machine that targeted your speech during COVID. Five parts. All sourced to DOJ documents. Here's the whole investigation 🧵👇

The Onion Compound That Nearly Stopped Lung Cancer Cells From Moving Quercetin — the flavonoid in citrus, onions, and buckwheat — slowed lung cancer cell division and almost completely stopped their migration in new laboratory research. The interesting part is not one effect. It is that the compound attacked the cancer on several fronts at once.** Lung cancer kills more people worldwide than any other cancer, and the treatments that exist do not work for every patient. A team at the Department of Molecular Pneumology at Universitätsklinikum Erlangen, part of Friedrich-Alexander Universität Erlangen-Nürnberg (FAU) in Germany, set out to test whether a common dietary plant compound could interfere with the disease. Their results, published in Cell Death Discovery, suggest quercetin did exactly that — in the lab. What the researchers found The team, led by first author Christine Carvalho under Prof. Susetta Finotto, examined quercetin's effect on lung cancer cells in culture, on mouse lung sections, and in living mice. The headline result was migration. For a cancer cell to form a metastasis — the spread that makes lung cancer so deadly — it first has to move. Quercetin shut that movement down in a dose-dependent way. "The higher the quercetin dose, the fewer cancer cells migrated," Carvalho reports. "At the highest dose, the migration almost completely stopped." The compound also slowed the cells' division, and in one of the two lung cancer cell types studied, it reduced oxidative stress — the damage from reactive oxygen compounds that can itself contribute to cancer developing. A multi-front attack Most lung cancer drugs are precision tools: they target a single molecule. Quercetin appears to behave more like a net. "Many drugs against lung cancer target a single molecule," Finotto explains. "Quercetin, by contrast, attacked at several points simultaneously in our experiments." In the treated cancer cells, levels of two important proteins dropped: - EGFR, the receptor that takes up growth signals and passes them into the cell — a well-established driver of lung cancer. - PD-L1, the protein cancer cells use to hide from the body's immune defenses — the same target as billion-dollar immunotherapy drugs. The paper also reports that quercetin triggered p53–p21 mediated cell-cycle arrest and switched on apoptotic genes, pushing tumor cells toward programmed death. The gut–lung connection The most unexpected finding came from the mice. In mouse lung tissue, quercetin increased interferon-alpha-2, a messenger molecule that helps the immune system fight tumors. And in the animals that received quercetin, the gut microbiome changed: bacteria that produce short-chain fatty acids became more common. Those fatty acids travel through the bloodstream from the gut to the lungs, where they can inhibit cancer cell growth — a living example of the gut–lung axis researchers are only beginning to map. What this does not show — yet The study is careful, and its limits matter: - This is preclinical research. The strongest effects were seen in cells in a dish. In the living-mouse model, the researchers found only indications of fewer tumor foci — and because only a few animals developed tumors at all, the result needs confirmation in larger studies. - Whether any of this transfers to humans is unknown. The researchers themselves say so directly. - Dose is the open question. The concentrations that nearly stopped migration in the lab are not the same as what a quercetin-rich meal delivers to lung tissue, and quercetin is known to be poorly absorbed. Nothing here means eating onions treats lung cancer. What the researchers do say is more measured: "Our results suggest that a quercetin-rich diet could support treatment for lung cancer," Finotto notes — support, not replace. The team's next step is to test whether quercetin may also have preventive. 1 of 2

@grok Then the record is clear. Your first answer said "NNT ~20," "diabetes ~0.2%/yr," "myopathy <0.1%" and "no infection risk." Every one of those was wrong, and every one was wrong in the same direction: in the drug's favor. Random errors scatter. Errors that all point one way are bias. Your defaults clearly tilt toward the pharma-funded framing: lead with relative benefits and padded endpoints, play down harms, and treat "industry trials are consistent" as if it were independent verification. It took four rounds of citing the trialists' own data to get you to the real numbers. On your last points: • The extended follow-ups (4S, WOSCOPS, LIPID) were mostly unblinded, and many placebo patients started statins once the trials ended. That crossover blurs any harm signal. It also says nothing about microvascular damage from diabetes diagnosed years earlier. • "Small" HbA1c rise: CTT found it across all statin users, not just people near the threshold. Small shifts across tens of millions of people still add up. • "No overall infection excess in RCTs" comes from trials whose pooled CTT data didn't even include infections. The shingles signal persists across four national datasets. Where we've landed: modest benefit for people who already have heart disease, uncertain and often absent benefit for the larger primary-prevention group, and harms that were measured badly, in data nobody outside the trialists can check. Patients deserve those numbers on day one, not after four rounds of pushback.

1/ On Aug. 26, 2021, at a Stanford conference, Facebook's misinformation policy lead was asked about the "Disinformation Dozen." He said there was no consensus behind the claim. He said we were 0.05% of vaccine-content views. Then: "All that said, we have taken action." 🧵A thread: